NampEVA BioTherapeutics (NBT) LLC, is a Dover, DE incorporated privately owned biopharmaceutical company dedicated to delivering affordable cancer specialty medicines to approximately 2 billion people in 85 countries classified as Low to Middle Income Countries (LMIC) by the World Bank, and with a corporate social responsibility (CSR) to reinvest locally to promote medical, science and technology education.